Becton Dickinson (BDX) Stock Overview
Develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
BDX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Becton, Dickinson and Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$192.59 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.28 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -20.87% |
| Change since IPO | 57.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| BDX | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 1.1% |
| 1Y | n/a | -23.3% | 6.0% |
Return vs Industry: Insufficient data to determine how BDX performed against the Swiss Medical Equipment industry.
Return vs Market: Insufficient data to determine how BDX performed against the Swiss Market.
Price Volatility
| BDX volatility | |
|---|---|
| BDX Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in CH Market | 8.4% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: BDX's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: Insufficient data to determine BDX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1897 | 72,000 | Tom Polen | www.bd.com |
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems.
Becton, Dickinson and Company Fundamentals Summary
| BDX fundamental statistics | |
|---|---|
| Market cap | CHF 40.78b |
| Earnings (TTM) | CHF 1.36b |
| Revenue (TTM) | CHF 16.94b |
Is BDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BDX income statement (TTM) | |
|---|---|
| Revenue | US$21.92b |
| Cost of Revenue | US$11.67b |
| Gross Profit | US$10.26b |
| Other Expenses | US$8.50b |
| Earnings | US$1.76b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.17 |
| Gross Margin | 46.78% |
| Net Profit Margin | 8.01% |
| Debt/Equity Ratio | 77.3% |
How did BDX perform over the long term?
See historical performance and comparisonDividends
Does BDX pay a reliable dividends?
See BDX dividend history and benchmarks| Becton Dickinson dividend dates | |
|---|---|
| Ex Dividend Date | Mar 10 2026 |
| Dividend Pay Date | Mar 31 2026 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 34 days |
Does BDX pay a reliable dividends?
See BDX dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/23 13:13 |
| End of Day Share Price | 2025/12/02 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Becton, Dickinson and Company is covered by 35 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Adam Feinstein | Barclays |
| Matthew Miksic | Barclays |